In The News
New heart syndrome identifies link among obesity, diabetes and kidney disease
Source: NBC News
As more Americans are being diagnosed with multiple chronic health problems at younger ages, for the first time, the American Heart Association is identifying a new medical condition that reflects the strong links among obesity, diabetes and heart and kidney disease.
A new treatment for obesity
Source: Harvard Health Publishing
On June 4, 2021, the FDA announced the long-anticipated approval of Wegovy, an injectable medication taken once per week for weight management.
16 tips to stop eating out of boredom
Source: Medical News Today
Eating when bored, as well as choosing unhealthy snacks, can have an undesirable impact on a person’s health and body weight. However, addressing diet, emotions, and behavioral habits are helpful strategies that people can try to reduce snacking out of boredom.
Study: Patients with severe obesity undergo bariatric surgery too late
Source: Medical Xpress
Patients in Scotland who are being assessed for weight loss surgery are older and have a higher weight than the international average, according to a new study funded by the National Institute for Health Research (NIHR).
Employer-based weight management program with access to anti-obesity medications results in greater weight loss
Source: Medical Xpress
A Cleveland Clinic study demonstrates that adults with obesity lost significantly more weight when they had access to medications for chronic weight management in conjunction with their employer-based weight management program, compared to adults who did not have access to the medications. The study was published in JAMA Network Open.
Digital self-monitoring effective for weight loss, healthy lifestyle
Source: Medical Xpress
Digital self-monitoring of physical activity and diet is an effective intervention to support weight loss in adults with obesity or overweight, according to a review published online June 30 in Obesity Reviews.
Patients report long-term favorable effects of weight loss surgery in their daily lives
Source: Medical Xpress
A new analysis from the STAMPEDE trial shows that over the course of five years, patients who had bariatric and metabolic surgery to treat uncontrolled type 2 diabetes reported greater physical health, more energy, less body pain, and less negative effects of diabetes in their daily lives, compared with patients who had medical therapy alone for their diabetes.
Resistance training: here`s why it`s so effective for weight loss
Source: Medical Xpress
Weight lifting, also known as resistance training, has been practised for centuries as a way of building muscular strength. Research shows that resistance training, whether done via body weight, resistance bands or machines, dumbbells or free weights, not only helps us build strength, but also improves muscle size and can help counteract age-related muscle loss.
Obesity Is the Main Contributor to Diabetes in Blacks and Whites
Source: The New York Times
Type 2 diabetes is almost twice as common in African-Americans as it is in whites. Obesity, rather than racial factors, is to blame, a new study in JAMA reports.
Researchers began with 4,251 black and white men and women ages 18 to 30 who were not diabetic. They then followed up with periodic interviews and health examinations over an average of 25 years. Compared to whites, black men were 67 percent more likely, and black women almost three times as likely, to develop diabetes.
Roux-en-Y gastric bypass better than gastric banding for rapid and safe weight loss
Source: MedicalNewsToday
A study published Online First by Archives of Surgery compared the effectiveness of two common forms of treatment for excessive weight gain: Roux-en-Y gastric bypass (RYGBP) and gastric banding (GB). The researchers found that for more sustainable and rapid weight loss, RYGBP is the better form of treatment.
In relation to the treatment of other comorbidities – other existing illnesses among the patients – RYBGP was also found to be more successful. Cholesterol levels in those who received GB remained unchanged, but those who received RYBGP saw a notable decrease. The lipid profile for those after RYGBP was "significantly better" after five years than for those in the GB group, as well as a lower mean fasting glucose level.
